45P: Extended follow-up confirmed real-world efficacy and safety of cemiplimab monotherapy in advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression
S. Masini , R. Alvarez Cabellos , I. De Elejoste Echebarria , M. Martinez Kareaga , M. Antonanzas Basa , M.C. Escoin Perez , F. Navarro , C. Traseira Puchol , L. Cabezon Gutierrez , S. Falagán Martínez , C. Garcia Benito , L. Masfarre Pinto , C. Avila Andrade , S. Sequero , J. Mosquera Martinez , E. Garcia Lorenzo , A. Azkárate Martínez , L. Paz-Ares , J. Zugazagoitia , J. Baena Espinar
{"title":"45P: Extended follow-up confirmed real-world efficacy and safety of cemiplimab monotherapy in advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression","authors":"S. Masini , R. Alvarez Cabellos , I. De Elejoste Echebarria , M. Martinez Kareaga , M. Antonanzas Basa , M.C. Escoin Perez , F. Navarro , C. Traseira Puchol , L. Cabezon Gutierrez , S. Falagán Martínez , C. Garcia Benito , L. Masfarre Pinto , C. Avila Andrade , S. Sequero , J. Mosquera Martinez , E. Garcia Lorenzo , A. Azkárate Martínez , L. Paz-Ares , J. Zugazagoitia , J. Baena Espinar","doi":"10.1016/S1556-0864(25)00240-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"20 3","pages":"Pages S39-S40"},"PeriodicalIF":21.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thoracic Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1556086425002400","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer,is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies.The readship includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.